The Senate passed S. 3187, the Food and Drug Administration Safety and Innovation Act, by a vote of 96-1.  The bill maintains the revisions to the drug shortage notification process that our group of 16 EMS/CCT-related organizations sought during the bill's development at the Committee level.  The Senate Health, Education, Labor and Pensions (HELP) Committee amended the statutory language in its bill to cover manufacturers of drugs used in the provision of emergency medical care and surgery and included all sterile injectable drugs as well. (The original draft included "life-supporting" and "life-sustaining" drugs, but did not make specific reference to drugs used in emergency situations.)